TrialQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2015

The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine.

Aaron Yarlas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.